Ali Murat Kahveci and Veysel Tahan 2019. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies . Turkish Journal of Gastroenterology. 27, 1 (Jul. 2019), 89–90.